Cancer Drug Costs
Brian discusses the complexities behind the high costs of cancer drugs, emphasizing the significant expenses involved in research and development. He highlights the competitive landscape between the US and China in cancer treatment advancements. Alie raises concerns about the soaring prices of medications like Revlimid, which, despite its life-saving potential, has generated billions for its parent company while patients struggle with affordability.In this clip
From this podcast
Ologies with Alie Ward
Hematology (BLOOD) with Brian Durie
Related Questions